Tech Company Financing Transactions
Navigating Cancer Funding Round
Navigating Cancer secured a $26 million Series D funding round on 9/18/2019. Investors included Merck Global Health Innovation Fund, TT Capital Partners and BrightEdge.
Transaction Overview
Merck Global Health Innovation Fund (Lead Investor) (David Rubin)
TT Capital Partners (Lead Investor) (Timothy Scallen)
BrightEdge (Robert Crutchfield)
Company Information
Seattle, WA 98104
USA
Management Team
Browse more venture capital transactions:
Prev: 9/17/2019: Crisp venture capital transaction
Next: 9/18/2019: Dental Intelligence venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs